Authors:
YAN L
OTTERNESS DM
KOZAK CA
WEINSHILBOUM RM
Citation: L. Yan et al., MOUSE NICOTINAMIDE N-METHYLTRANSFERASE GENE - MOLECULAR-CLONING, STRUCTURAL CHARACTERIZATION, AND CHROMOSOMAL LOCALIZATION, DNA and cell biology, 17(8), 1998, pp. 659-667
Authors:
HER C
WOOD TC
EICHLER EE
MOHRENWEISER HW
RAMAGLI LS
SICILIANO MJ
WEINSHILBOUM RM
Citation: C. Her et al., HUMAN HYDROXYSTEROID SULFOTRANSFERASE SULT2B1 - 2 ENZYMES ENCODED BY A SINGLE CHROMOSOME-19 GENE, Genomics (San Diego, Calif.), 53(3), 1998, pp. 284-295
Authors:
ANDERSEN JB
SZUMLANSKI C
WEINSHILBOUM RM
SCHMIEGELOW K
Citation: Jb. Andersen et al., PHARMACOKINETICS, DOSE ADJUSTMENTS, AND 6-MERCAPTOPURINE METHOTREXATEDRUG-INTERACTIONS IN 2 PATIENTS WITH THIOPURINE METHYLTRANSFERASE DEFICIENCY/, Acta paediatrica, 87(1), 1998, pp. 108-111
Authors:
YAN L
PREUSS CV
SZUMLANSKI CL
WEINSHILBOUM RM
Citation: L. Yan et al., HUMAN HISTAMINE N-METHYLTRANSFERASE (HNMT) PHARMACOGENETICS - COMMON GENETIC POLYMORPHISMS THAT ALTER ENZYME-ACTIVITY, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 413-413
Authors:
PREUSS CV
WOOD TC
SZUMLANSKI CL
RAFTOGIANIS RB
OTTERNESS DM
GIRARD B
SCOTT MC
WEINSHILBOUM RM
Citation: Cv. Preuss et al., HUMAN HISTAMINE N-METHYLTRANSFERASE PHARMACOGENETICS - COMMON GENETICPOLYMORPHISMS THAT ALTER ACTIVITY, Molecular pharmacology, 53(4), 1998, pp. 708-717
Citation: Dm. Otterness et al., HUMAN THIOPURINE METHYLTRANSFERASE PHARMACOGENETICS - KINDRED WITH A TERMINAL EXON SPLICE JUNCTION MUTATION THAT RESULTS IN LOSS OF ACTIVITY, The Journal of clinical investigation, 101(5), 1998, pp. 1036-1044
Citation: Dm. Otterness et al., THIOPURINE METHYLTRANSFERASE (TPMT) PHARMACOGENETICS - MECHANISM FOR LOSS OF ACTIVITY BY A SPLICE JUNCTION VARIANT ALLELE, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 70-70
Authors:
YAN L
OTTERNESS DM
WOOD TC
WEINSHILBOUM RM
Citation: L. Yan et al., HUMAN NICOTINAMIDE N-METHYLTRANSFERASE PHARMACOGENETICS - GENE SEQUENCE-ANALYSIS AND 5'-FLANKING REGION STUDY, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 76-76
Citation: Ct. Her et al., HUMAN SULFOTRANSFERASE SULT1C1 - CDNA CLONING, TISSUE-SPECIFIC EXPRESSION, AND CHROMOSOMAL LOCALIZATION, Genomics, 41(3), 1997, pp. 467-470
Authors:
LEWIS LD
BENIN A
SZUMLANSKI CL
OTTERNESS DM
LENNARD L
WEINSHILBOUM RM
NIERENBERG DW
Citation: Ld. Lewis et al., OLSALAZINE AND 6-MERCAPTOPURINE-RELATED BONE-MARROW SUPPRESSION - A POSSIBLE DRUG-DRUG INTERACTION, Clinical pharmacology and therapeutics, 62(4), 1997, pp. 464-475
Authors:
YAN L
OTTERNESS DM
CRADDOCK TL
WEINSHILBOUM RM
Citation: L. Yan et al., MOUSE-LIVER NICOTINAMIDE N-METHYLTRANSFERASE - CDNA CLONING, EXPRESSION, AND NUCLEOTIDE-SEQUENCE POLYMORPHISMS, Biochemical pharmacology, 54(10), 1997, pp. 1139-1149
Citation: Rb. Raftogianis et al., PHENOL SULFOTRANSFERASE PHARMACOGENETICS IN HUMANS - ASSOCIATION OF COMMON SULT1A1 ALLELES WITH TS PST PHENOTYPE, Biochemical and biophysical research communications, 239(1), 1997, pp. 298-304
Authors:
DAVID CL
SZUMLANSKI CL
DEVRY CG
PARKHAH JO
CLARKE S
WEINSHILBOUM RM
ASWAD DW
Citation: Cl. David et al., HUMAN ERYTHROCYTE PROTEIN L-ISOASPARTYL METHYLTRANSFERASE - HERITABILITY OF BASAL ACTIVITY AND GENETIC-POLYMORPHISM FOR THERMAL-STABILITY, Archives of biochemistry and biophysics, 346(2), 1997, pp. 277-286
Citation: Dm. Otterness et al., HUMAN THIOPURINE METHYLTRANSFERASE PHARMACOGENETICS - IDENTIFICATION OF A NOVEL VARIANT ALLELE, Journal of investigative medicine, 44(3), 1996, pp. 248-248
Citation: Rb. Raftogianis et al., HUMAN HISTAMINE N-METHYLTRANSFERASE GENE - STRUCTURAL CHARACTERIZATION AND CHROMOSOMAL LOCALIZATION, Journal of investigative medicine, 44(3), 1996, pp. 253-253
Authors:
HER C
AKSOY IA
SZUMLANSKI CL
WEINSHILBOUM RM
Citation: C. Her et al., DEHYDROEPIANDROSTERONE SULFOTRANSFERASE AND ESTROGEN SULFOTRANSFERASEIN HUMAN JEJUNUM - IMMUNOCHEMICAL CHARACTERIZATION OF INDIVIDUAL VARIATION, Journal of investigative medicine, 44(3), 1996, pp. 303-303
Authors:
LACHMAN HM
PAPOLOS DF
SAITO T
YU YM
SZUMLANSKI CL
WEINSHILBOUM RM
Citation: Hm. Lachman et al., HUMAN CATECHOL-O-METHYLTRANSFERASE PHARMACOGENETICS - DESCRIPTION OF A FUNCTIONAL POLYMORPHISM AND ITS POTENTIAL APPLICATION TO NEUROPSYCHIATRIC DISORDERS, Pharmacogenetics, 6(3), 1996, pp. 243-250
Authors:
SCHELLER T
ORGACKA H
SZUMLANSKI CL
WEINSHILBOUM RM
Citation: T. Scheller et al., MOUSE-LIVER NICOTINAMIDE N-METHYLTRANSFERASE PHARMACOGENETICS - BIOCHEMICAL-PROPERTIES AND VARIATION IN ACTIVITY AMONG INBRED STRAINS, Pharmacogenetics, 6(1), 1996, pp. 43-53
Authors:
WOOD TC
HER C
AKSOY I
OTTERNESS DM
WEINSHILBOUM RM
Citation: Tc. Wood et al., HUMAN DEHYDROEPIANDROSTERONE SULFOTRANSFERASE PHARMACOGENETICS - QUANTITATIVE WESTERN ANALYSIS AND GENE SEQUENCE POLYMORPHISMS, Journal of steroid biochemistry and molecular biology, 59(5-6), 1996, pp. 467-478
Citation: Ct. Her et al., HUMAN PHENOL SULFOTRANSFERASE STP2 GENE - MOLECULAR-CLONING, STRUCTURAL CHARACTERIZATION, AND CHROMOSOMAL LOCALIZATION, Genomics, 33(3), 1996, pp. 409-420
Authors:
HER C
SZUMLANSKI C
AKSOY IA
WEINSHILBOUM RM
Citation: C. Her et al., HUMAN JEJUNAL ESTROGEN SULFOTRANSFERASE AND DEHYDROEPIANDROSTERONE SULFOTRANSFERASE - IMMUNOCHEMICAL CHARACTERIZATION OF INDIVIDUAL VARIATION, Drug metabolism and disposition, 24(12), 1996, pp. 1328-1335
Authors:
CUOMO R
PUMPO R
CASTALDO G
CALCAGNO G
WEINSHILBOUM RM
SALVATORE F
BUDILLON G
Citation: R. Cuomo et al., THE EXPRESSION OF NICOTINAMIDE N-METHYLTRANSFERASE MESSENGER-RNA IN HUMAN LIVER-CANCER AND SURROUNDING CIRRHOTIC TISSUE, Gastroenterology, 110(4), 1996, pp. 1176-1176